These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 33826221)

  • 1. Subtle differences in autonomic symptoms in people diagnosed with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
    Martinez KL; Mauss C; Andrews J; Saboda K; Huynh JM; Sanoja AJ; Jesudas R; Byers PH; Laukaitis CM
    Am J Med Genet A; 2021 Jul; 185(7):2012-2025. PubMed ID: 33826221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting quality of life in children and adolescents with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorders.
    Mu W; Muriello M; Clemens JL; Wang Y; Smith CH; Tran PT; Rowe PC; Francomano CA; Kline AD; Bodurtha J
    Am J Med Genet A; 2019 Apr; 179(4):561-569. PubMed ID: 30703284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Spider: a visual, multisystemic symptom impact questionnaire for people with hypermobility-related disorders-validation in adults.
    Ewer ER; De Pauw R; Kazkazk H; Ninis N; Rowe P; Simmonds JV; De Wandele I
    Clin Rheumatol; 2024 Sep; 43(9):3005-3017. PubMed ID: 39085705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics of patients with hypermobile type Ehlers-Danlos syndrome (hEDS) and generalized hypermobility spectrum disorders (G-HSD): an online survey.
    Teran-Wodzinski P; Kumar A
    Rheumatol Int; 2023 Oct; 43(10):1935-1945. PubMed ID: 37378685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rome IV Functional Gastrointestinal Disorders and Health Impairment in Subjects With Hypermobility Spectrum Disorders or Hypermobile Ehlers-Danlos Syndrome.
    Lam CY; Palsson OS; Whitehead WE; Sperber AD; Tornblom H; Simren M; Aziz I
    Clin Gastroenterol Hepatol; 2021 Feb; 19(2):277-287.e3. PubMed ID: 32109633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermal fibroblast-to-myofibroblast transition sustained by αvß3 integrin-ILK-Snail1/Slug signaling is a common feature for hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
    Zoppi N; Chiarelli N; Binetti S; Ritelli M; Colombi M
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt A):1010-1023. PubMed ID: 29309923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of the 2017 diagnostic criteria for hEDS by the Toronto GoodHope Ehlers-Danlos syndrome clinic: A retrospective review.
    McGillis L; Mittal N; Santa Mina D; So J; Soowamber M; Weinrib A; Soever L; Rozenberg D; Liu L; Tse Y; Katz J; Charames GS; Murphy K; Vadas P; Slepian MP; Walsh S; Wilson L; Adler A; Franzese A; Hussey L; Nevay DL; Guzman J; Clarke H
    Am J Med Genet A; 2020 Mar; 182(3):484-492. PubMed ID: 31840928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional gastrointestinal disorders are increased in joint hypermobility-related disorders with concomitant postural orthostatic tachycardia syndrome.
    Tai FWD; Palsson OS; Lam CY; Whitehead WE; Sperber AD; Tornblom H; Simren M; Aziz I
    Neurogastroenterol Motil; 2020 Dec; 32(12):e13975. PubMed ID: 32803794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severity classes in adults with hypermobile Ehlers-Danlos syndrome/hypermobility spectrum disorders: a pilot study of 105 Italian patients.
    Copetti M; Morlino S; Colombi M; Grammatico P; Fontana A; Castori M
    Rheumatology (Oxford); 2019 Oct; 58(10):1722-1730. PubMed ID: 30783660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fear avoidance, fear of falling, and pain disability in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.
    Chuchin JD; Ornstein TJ
    Disabil Rehabil; 2024 Sep; 46(18):4234-4245. PubMed ID: 37843031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Looking back and beyond the 2017 diagnostic criteria for hypermobile Ehlers-Danlos syndrome: A retrospective cross-sectional study from an Italian reference center.
    Ritelli M; Chiarelli N; Cinquina V; Vezzoli M; Venturini M; Colombi M
    Am J Med Genet A; 2024 Feb; 194(2):174-194. PubMed ID: 37774134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laryngological Complaint Prevalence in Hypermobile Ehlers-Danlos or Hypermobility Spectrum Disorders.
    Menton SM; Fairweather D; Bruno KA; Thompson CC; Candelo E; Darakjian AA; Gehin JM; Jain A; Kotha A; Whelan ER; Li Z; Knight DRT; Rutt AL
    Laryngoscope; 2024 Feb; 134(2):773-778. PubMed ID: 37597175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypermobile Ehlers-Danlos syndrome and disorders of the gastrointestinal tract: What the gastroenterologist needs to know.
    Thwaites PA; Gibson PR; Burgell RE
    J Gastroenterol Hepatol; 2022 Sep; 37(9):1693-1709. PubMed ID: 35750466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of kinesiophobia and its correlations with pain and fatigue in joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type.
    Celletti C; Castori M; La Torre G; Camerota F
    Biomed Res Int; 2013; 2013():580460. PubMed ID: 23936820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysautonomia in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders is associated with exercise intolerance and cardiac atrophy.
    Ruiz Maya T; Fettig V; Mehta L; Gelb BD; Kontorovich AR
    Am J Med Genet A; 2021 Dec; 185(12):3754-3761. PubMed ID: 34331416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthcare experiences among adults with hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorder in the United States.
    Estrella E; Frazier PA
    Disabil Rehabil; 2024 Feb; 46(4):731-740. PubMed ID: 36772820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low- and high-anxious hypermobile Ehlers-Danlos syndrome patients: comparison of psychosocial and health variables.
    Baeza-Velasco C; Bourdon C; Montalescot L; de Cazotte C; Pailhez G; Bulbena A; Hamonet C
    Rheumatol Int; 2018 May; 38(5):871-878. PubMed ID: 29497845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are patients with hypermobile Ehlers-Danlos syndrome or hypermobility spectrum disorder so different?
    Aubry-Rozier B; Schwitzguebel A; Valerio F; Tanniger J; Paquier C; Berna C; Hügle T; Benaim C
    Rheumatol Int; 2021 Oct; 41(10):1785-1794. PubMed ID: 34398260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypermobile Ehlers-Danlos syndromes: Complex phenotypes, challenging diagnoses, and poorly understood causes.
    Gensemer C; Burks R; Kautz S; Judge DP; Lavallee M; Norris RA
    Dev Dyn; 2021 Mar; 250(3):318-344. PubMed ID: 32629534
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.